Tibet Rhodiola Pharmaceutical Holding Co. Announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 628.551 million compared to CNY 618.845 million a year ago. Operating income was CNY 249.402 million compared to CNY 177.588 million a year ago. Net income was CNY 219.907 million compared to CNY 157.347 million a year ago. Basic earnings per share from continuing operations was CNY 1.1 compared to CNY 0.89 a year ago.